Moberg Pharma AB (publ) (MOB) — Net Asset Quality Index
Moberg Pharma AB (publ) (MOB) has a Net Asset Quality Index of 97.5% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Skr682.26 Million minus total liabilities of Skr17.04 Million yields net assets of Skr665.22 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check Moberg Pharma AB (publ) asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Moberg Pharma AB (publ) Net Asset Quality Index Over Time (2008–2025)
This chart shows how Moberg Pharma AB (publ)'s Net Asset Quality Index has evolved across 18 annual periods from 2008 to 2025. As of December 2025, the index stands at 97.5%, representing net assets of Skr665.22 Million against total assets of Skr682.26 Million SEK. See Moberg Pharma AB (publ) (MOB) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Moberg Pharma AB (publ) (2008–2025)
The table below presents the year-by-year Net Asset Quality Index for Moberg Pharma AB (publ) from 2008 to 2025, covering 18 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see MOB market cap overview.
| Year | Quality Index | Net Assets (SEK) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 97.5% | Skr665.22 Million | Skr682.26 Million | Skr17.04 Million | ▲ +0.2 pp |
| 2024 | 97.3% | Skr686.82 Million | Skr706.09 Million | Skr19.27 Million | ▲ +1.1 pp |
| 2023 | 96.2% | Skr610.73 Million | Skr634.73 Million | Skr24.01 Million | ▲ +1.7 pp |
| 2022 | 94.5% | Skr533.58 Million | Skr564.42 Million | Skr30.84 Million | ▼ -1.7 pp |
| 2021 | 96.3% | Skr434.05 Million | Skr450.89 Million | Skr16.84 Million | ▲ +14.0 pp |
| 2020 | 82.3% | Skr395.58 Million | Skr480.58 Million | Skr85.00 Million | ▲ +1.4 pp |
| 2019 | 80.9% | Skr105.68 Million | Skr130.59 Million | Skr24.91 Million | ▲ +33.5 pp |
| 2018 | 47.5% | Skr594.02 Million | Skr1.25 Billion | Skr657.60 Million | ▲ +2.3 pp |
| 2017 | 45.2% | Skr552.41 Million | Skr1.22 Billion | Skr670.85 Million | ▼ -0.4 pp |
| 2016 | 45.6% | Skr561.62 Million | Skr1.23 Billion | Skr670.55 Million | ▼ -43.2 pp |
| 2015 | 88.8% | Skr352.82 Million | Skr397.45 Million | Skr44.63 Million | ▲ +4.3 pp |
| 2014 | 84.4% | Skr303.75 Million | Skr359.72 Million | Skr55.97 Million | ▲ +10.3 pp |
| 2013 | 74.2% | Skr201.49 Million | Skr271.61 Million | Skr70.11 Million | ▲ +10.7 pp |
| 2012 | 63.5% | Skr178.23 Million | Skr280.76 Million | Skr102.53 Million | ▼ -19.6 pp |
| 2011 | 83.1% | Skr76.79 Million | Skr92.45 Million | Skr15.67 Million | ▲ +77.5 pp |
| 2010 | 5.6% | Skr687.70K | Skr12.38 Million | Skr11.69 Million | ▼ -80.0 pp |
| 2009 | 85.6% | Skr30.21 Million | Skr35.30 Million | Skr5.09 Million | ▲ +18.2 pp |
| 2008 | 67.4% | Skr15.23 Million | Skr22.59 Million | Skr7.36 Million | — |